Navegar por autor "Rua-Figueroa, I."

Mostrando ítems 1-5 de 5

Biologic therapy in refractory non-multiple sclerosis optic neuritis isolated or associated to immune-mediated inflammatory diseases. A multicenter study

2020- Herrero-Morant, A.; Alvarez-Reguera, C.; Martin-Varillas, J. L.; Calvo-Rio, V.; Casado, A.; [et al.]
Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort

2019- Tejera Segura, B.; Rua-Figueroa, I.; Pego Reigosa, José María; del Campo Pérez, Victor Miguel; Wincup, C.; [et al.]
Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry

2015- Fernandez-Nebro, A.; Rua-Figueroa, I.; Lopez-Longo, F. J.; Galindo-Izquierdo, M.; Calvo-Alen, J.; [et al.]
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

2020- Sanchez-Piedra, C.; Diaz-Torne, C.; Manero, J.; Pego Reigosa, José María; Rua-Figueroa, I.; [et al.]
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry

2019- Mena-Vazquez, N.; Fernandez-Nebro, A.; Pego Reigosa, José María; Galindo, M.; Melissa-Anzola, A.; [et al.]